Stay updated on ARGX-110 with Azacytidine in AML Clinical Trial

Sign up to get notified when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARGX-110 with Azacytidine in AML Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The clinical trial record for ARGX-110 with azacytidine is displayed, including study design, eligibility criteria, locations, and outcome measures. The record also shows that the study is completed and no longer recruiting.
    Difference
    54%
    Check dated 2026-11-07T12:51:52.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-31T13:30:32.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH terminology transition, saying some content may use “Super Intelligence” instead of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T17:02:24.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.1 to v3.7.2. The study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T16:42:47.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error for the study record. The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T17:15:19.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content. This indicates restricted access to the NCT03030612 page and blocks viewing the study details in ClinicalTrials.gov.
    Difference
    19%
    Check dated 2026-09-19T20:17:34.000Z thumbnail image

Stay in the know with updates to ARGX-110 with Azacytidine in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARGX-110 with Azacytidine in AML Clinical Trial page.